Viewing Study NCT05257993


Ignite Creation Date: 2025-12-25 @ 1:11 AM
Ignite Modification Date: 2025-12-25 @ 1:11 AM
Study NCT ID: NCT05257993
Status: RECRUITING
Last Update Posted: 2025-02-19
First Post: 2022-02-03
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Study to Assess the Safety, Tolerability of JPI-547 in Combination With Modified FOLFIRINOX or Gemcitabine-nab-paclitaxel in Patients With Locally Advanced and Metastatic Pancreatic Cancer
Sponsor: Onconic Therapeutics Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module